Large Cell Neuroendocrine Carcinoma Transformation and EGFR -T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer-Reference-Cited by-同舟云学术

Large Cell Neuroendocrine Carcinoma Transformation and EGFR -T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer

Published:2017-08 Issue:8 Volume:92 Page:1304-1311
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Baglivo Sara,Ludovini Vienna,Sidoni Angelo,Metro Giulio,Ricciuti Biagio,Siggillino Annamaria,Rebonato Alberto,Messina Salvatore,Crinò Lucio,Chiari Rita

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice;Pirker;Cancer Metastasis Rev,2016

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci Transl Med,2011

5. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin;Oser;Lancet Oncol,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histologic transformation of non‐small‐cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms;Cancer Science;2024-05-27

2. Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer;Translational Lung Cancer Research;2024-01

3. Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review;Translational Lung Cancer Research;2023-04

4. Targeting ALK in Neuroendocrine Tumors of the Lung;Frontiers in Oncology;2022-06-07

5. In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma;International Journal of Cancer;2021-11-10